AzTrials
AzTrials

Sensory Processing DisorderNCT07656961

Ayres Sensory Integration Test Evaluation Results and Neurodevelopmentally Focused Counseling in Children With Neurodevelopmental Problems

An observational study of Sensory Processing Disorder and Neurodevelomental Disorders, run by Yeditepe University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the study is to investigate the long-term effects of ASI-based and hybrid neurodevelopmental counseling services on the variables of the Ayres Sensory Integration Assessment Test in children with neurodevelopmental disorders. Read more about this study

Who is it for?
Ages 3 to 12 yearsHealthy volunteers can take part
How many people
16 participants
Where
1 siteTurkey (Türkiye)
Study dates
18 Jun 2026to 16 Jan 2027
How long will I take part?
1 Month
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: The study population will consist of children aged 3 to 12 years with diagnosed or suspected neurodevelopmental problems who apply to the YUGEM Sensory Perception Motor Unit at Yeditepe University. Children referred for neurodevelopmental follow-up and considered suitable for the Evaluation in Ayres Sensory Integration assessment will be included in the study.

Who may be able to join

  • Aged 3-12
  • Sensory sensitivity (excessive or under-reaction to tactile, movement, auditory, or visual stimuli)
  • Have been referred by a pediatrician for neurodevelopmental monitoring
  • Have coordination difficulties
  • Difficulty organizing gross and/or fine motor movements
  • Activity level significantly above or below the norm for their age
  • Delays in academic achievement
  • Difficulties with daily living skills such as dressing and personal hygiene

Who cannot join

  • Being under 3 years of age or over 12 years of age
  • Having no conditions that fall outside normal developmental parameters

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Elif Develi, PhD contact

+90 555 593 62 93

elifstn@yahoo.com

Turkey (Türkiye)1 site
  • Yeditepe University

    Istanbul, Ataşehir, 34755

Other trials in Turkey (Türkiye)

About this study

The aim of the study is to investigate the long-term effects of ASI-based and hybrid neurodevelopmental counseling services on the variables of the Ayres Sensory Integration Assessment Test in children with neurodevelopmental disorders.

Read the detailed description

After application to the YUGEM Sensory Perception Motor Unit, the child and family will undergo a preliminary assessment. Following the necessary interviews and psychiatric consultation, specialists will decide whether the child is suitable for the Evaluation in Ayres Sensory Integration (EASI).

Children who are considered suitable for the EASI assessment will be evaluated through a multidisciplinary approach. The data obtained from the assessment will be analyzed using computer-based statistical software, and the results will be reviewed by the specialists. Based on these results, the frequency, duration, and delivery method of sensory integration therapy will be determined according to the needs of the child and family.

Neurodevelopmentally focused therapy counseling based on Ayres Sensory Integration principles will be planned either face-to-face or remotely, as appropriate for the child and family. After this decision, a meeting will be held with the family to plan the child's therapy process. There will be a 6-month therapy-counseling process.

Keywords
Neurodevelopmental Disorders, Sensory Integration, EASI
Medical subject headings
Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07656961
Study groupRoleWhat they receive
Children With Neurodevelopmental DisordersChildren aged 3 to 12 years with neurodevelopmental disorders who applied to the YUGEM Sensory Perception Motor Unit and are considered suitable for the Evaluation in Ayres Sensory Integration assessment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Evaluation of Ayres Sensory Integration (EASI)

    The Evaluation of Ayres Sensory Intergation test measures sensory perception, postural/ocular/bilateral motor integration, praxis, and sensory reactivity in a way that minimizes the effects of culture, language comprehension, and prior experience. The EASI tests are designed for children aged 3-12 and will be administered by appropriately trained professionals.

    Measured: 4 Weeks

  2. Pediatric Sensory Profile

    This is a measure consisting of three main sections used in children. These are; sensory processing, modulation and behavioral and emotional responses. The subgroups of each main section (14 sections in total, 125 questions) are tested. This scale is administered by the caregiver.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2026
  2. Study start18 Jun 2026 (estimated)
  3. Primary completion16 Jul 2026 (estimated)
  4. Study completion16 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
16 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT07656961
Sponsor's protocol ID
125
Status last verified
Jun 2026
First submitted
15 Jun 2026
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: It's not decided.

Questions about this trial

What is this clinical trial studying?

An observational study of Sensory Processing Disorder and Neurodevelomental Disorders, run by Yeditepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elif Develi, PhD (+90 555 593 62 93, elifstn@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Evaluation of Ayres Sensory Integration (EASI) (time frame: 4 Weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in